Advisories For Registrants
June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
June 10th, 2024
Important Safety and Efficacy Information on ALBRIOZA (sodium phenylbutyrate and ursodoxicoltaurine) – Market Withdrawal and Continued Restricted Access
June 6th, 2024
Importation of USA-authorized Carbamazepine Extended-Release Tablets, USP 200 mg and 400 mg due to the current shortage of Canadian-authorized carbamazepine
Advisories For The Public
August 5th, 2024
Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks
August 5th, 2024
JAMP Digoxin 0.0625 mg and 0.125 mg tablets recalled due to possible incorrect dose, which may pose health risks
July 29th, 2024
Various multivitamins and supplements distributed across Canada are being recalled because they may contain metal fibres
July 26th, 2024
Incorrect dosing information on the “SAVE ME” instructional card in the Naloxone Take Home Kit by Canadian Hospital Specialties Ltd
June 17th, 2024
Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site
June 10th, 2024
Accel-Ondansetron ODT, Mint-Betahistine and PMS-Pirfenidone tablets recalled due to data integrity concerns
Health Canada Notices of Restriction
Health Canada’s List of Restricted Health Care Practitioners and Pharmacists Named in a Notice of Restriction is a filterable database that is updated four times a year. The list represents the licensed health care practitioners and pharmacists who have been restricted from having narcotics, controlled drugs, and/or targeted substances sold or provided to them, except when dispensed to them as patients themselves, and whose restrictions are published on the relevant professional provincial or territorial licensing authority’s website.
Please note that the list does not represent a complete listing of all notices of restriction currently in effect but is intended to provide interested parties timely access to information on new restrictions online and allow regulated parties to better comply with regulatory requirements.
Health Product InfoWatch
Year-to-Date
Safe Medication Use Newsletter
Year-to-Date
- January 24, 2024 – Are Your Medications Ready to Use?
- February 29, 2024 – Your Report Makes a Difference
- March 13, 2024 – Out with the Old: Return Your Used or Out-of-Date Eye and Ear Drops to the Pharmacy
- April 23, 2024 – Knowledge is Power: Informed Consumers Prevent Medication Errors
- May 22, 2024 – Power of Partnerships: Building a Strong Patient-Provider Relationship Part 2 of a 3-Part Series
- June 11, 2024 – The Power of Words: Improving Labels and Packages for Medication Safety Part 3 of a 3-Part Series
- July 24, 2024 – Safe Spaces: Feeling Comfortable to Speak Up
Institute for Safe Medication Practices (ISMP) Canada Safety Bulletin
Year-to-Date
- February 14, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 1
- March 6, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 2
- March 26, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 3
- April 30, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 4
- May 29, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 5
- June 18, 2024 – ISMP Canada Safety Bulletin Volume 24, Issue 6
Institute for Safe Medication Practices (ISMP) Canada Education Events
Upcoming
-
- August 24 & 25, 2024 – Incident Analysis and Proactive Risk Assessment
- September 21, 2024 – Medication Reconciliation and Best Possible Medication History
- September 28 & 29, 2024 – Multi-Incident Analysis and Medication Safety Culture